Treat with Oral Iron Supplementation Immediately
This pregnant patient with ferritin 4 ng/mL and hemoglobin 10 g/dL has iron deficiency anemia and should be started on oral iron therapy as first-line treatment. 1, 2, 3
Diagnostic Confirmation
Your patient clearly has iron deficiency anemia (IDA):
- Ferritin 4 ng/mL is severely depleted (diagnostic threshold for ID in pregnancy is <30 μg/L) 1, 4
- Hemoglobin 10 g/dL meets criteria for anemia in pregnancy (threshold <11 g/dL in first and third trimester, <10.5 g/dL in second trimester) 5, 3
Treatment Algorithm
First-Line: Oral Iron
- Start oral ferrous iron 100 mg daily (elemental iron), taken between meals for optimal absorption 5
- Alternative dosing: Alternate-day dosing can be considered to reduce gastrointestinal side effects while maintaining efficacy 1
- Continue throughout pregnancy to delivery 5
Monitoring Response
- Recheck hemoglobin in 2 weeks 5
- If hemoglobin increases ≥10 g/L, oral therapy is working—continue it
- If hemoglobin fails to increase ≥10 g/L after 2 weeks, switch to intravenous iron 5
When to Use IV Iron Instead
Switch to intravenous iron if: 1, 2, 3
- Oral iron intolerance (nausea, constipation, diarrhea)
- Lack of response to oral iron after 2 weeks
- Third trimester (consider as first-line due to time constraints)
- Clinical need for rapid correction
The most recent 2026 Canadian guideline 3 and 2025 Australian consensus 1 both strongly support this approach, with oral iron as first-line for mild-moderate IDA and IV iron reserved for specific circumstances.
Critical Pitfalls to Avoid
Do not delay treatment. While the 2015 USPSTF guideline 6 states "insufficient evidence" for screening and treatment benefits on hard outcomes, this reflects methodological limitations in proving population-level benefit—not a recommendation against treating diagnosed IDA. The ACOG recommendation cited within that same guideline explicitly states to treat iron deficiency anemia with supplemental iron 6.
Do not wait for symptoms. Iron deficiency causes physical and neuropsychological symptoms (lethargy, altered mood, poor concentration) and fetal neurocognitive impairment even before anemia develops 1.
Target Goals
- Hemoglobin: 11-12 g/dL (normalization) 7
- Ferritin: >30 μg/L at minimum, ideally >100 μg/L to replenish stores 1, 7
- Recheck ferritin at 36 weeks if clinically indicated 1
Evidence Strength Discussion
The most recent high-quality evidence from 2025-2026 1, 8, 4, 3 provides clear diagnostic thresholds and treatment algorithms, superseding the 2015 USPSTF "insufficient evidence" statement. The 2026 propensity-matched cohort 8 demonstrated that IV iron reduces preterm labor and cesarean section rates compared to oral iron, though oral iron remains appropriate first-line for mild-moderate cases. The key is treating diagnosed IDA, not debating whether to screen asymptomatic women—your patient is already diagnosed.